EUVIMEDEUVIMED entdecken
Open Access

Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS ‐ CoV ‐2 Vaccination

Carmen Cuéllar iD, Marta Rodero, Juan González-Fernández iD, Lorena Galindo-Regal, Francisca López-Chuliá, Carlos García-Ballesteros, Leonor Fernández-Murga, Antonio Llombart-Cussac iD, María Victoria Domínguez-Márquez, Juan Carlos Andreu-Ballester iD

Parasite Immunology · 2026

DOI: 10.1111/pim.70101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasite Immunology, 2026. Verfasst von Carmen Cuéllar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Parasitology Department, Complutense University, Madrid, Spain. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antigens, Helminth, Anisakis. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Conselleria de Sanitat Universal i Salut Pública, EU Operational Program of the European Regional Development Fund (ERDF), European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parasitic infections can induce immunomodulatory effects that may influence host responses to vaccination. Chronic exposure to Anisakis antigens could modify T‐cell and antibody profiles, potentially affecting SARS‐CoV‐2 vaccine effectiveness in endemic populations. We aimed to determine whether prior exposure to Anisakis alters SARS‐CoV‐2 vaccine‐induced immunity. Forty healthy volunteers were evaluated at five time points before and after receiving either the Pfizer‐BioNTech or Oxford‐AstraZeneca COVID‐19 vaccines. Serum levels of anti‐ Anisakis and anti‐SARS‐CoV‐2 antibodies were quantified by ELISA, whereas T‐ and B‐cell subsets and apoptosis rates were analysed by flow cytometry. SARS‐CoV‐2 vaccination induced significant changes in anti‐ Anisakis antibody levels, particularly IgG and IgA, which increased after the second dose and persisted throughout follow‐up. Individuals seropositive for anti‐ Anisakis antibodies exhibited higher post‐vaccination anti‐SARS‐CoV‐2 IgG levels, and anti‐ Anisakis IgA positivity correlated with stronger anti‐SARS‐CoV‐2 IgA responses at specific time points. Positive associations were also observed between anti‐ Anisakis antibody levels and circulating T‐ and B‐cell subsets. Prior sensitization to Anisakis antigens appears to influence both the magnitude and quality of the adaptive immune response elicited by SARS‐CoV‐2 vaccination, affecting antibody profiles and lymphocyte subset dynamics. Conversely, COVID‐19 vaccination can alter humoral reactivity to Anisakis antigens, indicating bidirectional immunomodulation between parasite exposure and vaccine‐induced immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Antigens, HelminthAnisakisCOVID-19 VaccinesAnisakiasisHumansAnimalsMaleFemaleImmunoglobulin GAdultImmunoglobulin AAntibodies, HelminthAntibodies, ViralVaccinationYoung AdultMiddle Aged

Stichwörter der Autor:innen

Anisakis simplexB cellsCOVID‐19 vaccineT cellsantibody responseimmunomodulation

Substanzen

Antigens, HelminthImmunoglobulin GImmunoglobulin AAntibodies, HelminthAntibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Microbiology and Parasitology Department, Complutense University, Madrid, Spain.
  • FISABIO Foundation, Valencia, Spain.
  • Laboratory of Molecular Biology and Research Department, Arnau de Vilanova University Hospital, FISABIO Foundation, Valencia, Spain.
  • Hematology Department, Arnau de Vilanova Hospital, Valencia, Spain.
  • Molecular Oncology Laboratory, Arnau de Vilanova Hospital, Valencia, Spain.
  • Oncology Department, Arnau de Vilanova Hospital, Valencia, Spain.

ORCID-Profile: Carmen Cuéllar, Juan González-Fernández, Antonio Llombart-Cussac, Juan Carlos Andreu-Ballester

Förderung

  • Conselleria de Sanitat Universal i Salut Pública
  • EU Operational Program of the European Regional Development Fund (ERDF)
  • European Regional Development Fund

Zitieren

APA

Cuéllar, C., Rodero, M., González-Fernández, J., Galindo-Regal, L., López-Chuliá, F., García-Ballesteros, C., Fernández-Murga, L., Llombart-Cussac, A., Domínguez-Márquez, M. V., & Andreu-Ballester, J. C. (2026). Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS ‐ CoV ‐2 Vaccination. Parasite Immunology. https://doi.org/10.1111/pim.70101

Vancouver

Cuéllar C, Rodero M, González-Fernández J, Galindo-Regal L, López-Chuliá F, García-Ballesteros C, et al. Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS ‐ CoV ‐2 Vaccination. Parasite Immunology. 2026. doi:10.1111/pim.70101

BibTeX
@article{Cullar2026,
  author = {Cuéllar, Carmen and Rodero, Marta and González-Fernández, Juan and Galindo-Regal, Lorena and López-Chuliá, Francisca and García-Ballesteros, Carlos and Fernández-Murga, Leonor and Llombart-Cussac, Antonio and Domínguez-Márquez, María Victoria and Andreu-Ballester, Juan Carlos},
  title = {Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS ‐ CoV ‐2 Vaccination},
  journal = {Parasite Immunology},
  year = {2026},
  doi = {10.1111/pim.70101}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche